Correlation Between 00108WAF7 and Aerovate Therapeutics
Specify exactly 2 symbols:
By analyzing existing cross correlation between AEP TEX INC and Aerovate Therapeutics, you can compare the effects of market volatilities on 00108WAF7 and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 00108WAF7 with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 00108WAF7 and Aerovate Therapeutics.
Diversification Opportunities for 00108WAF7 and Aerovate Therapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between 00108WAF7 and Aerovate is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding AEP TEX INC and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and 00108WAF7 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AEP TEX INC are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of 00108WAF7 i.e., 00108WAF7 and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between 00108WAF7 and Aerovate Therapeutics
Assuming the 90 days trading horizon AEP TEX INC is expected to generate 0.55 times more return on investment than Aerovate Therapeutics. However, AEP TEX INC is 1.82 times less risky than Aerovate Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Aerovate Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 7,551 in AEP TEX INC on December 2, 2024 and sell it today you would lose (12.00) from holding AEP TEX INC or give up 0.16% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 72.13% |
Values | Daily Returns |
AEP TEX INC vs. Aerovate Therapeutics
Performance |
Timeline |
AEP TEX INC |
Aerovate Therapeutics |
00108WAF7 and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 00108WAF7 and Aerovate Therapeutics
The main advantage of trading using opposite 00108WAF7 and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 00108WAF7 position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.00108WAF7 vs. Summit Environmental | 00108WAF7 vs. Anheuser Busch Inbev | 00108WAF7 vs. Insteel Industries | 00108WAF7 vs. National Beverage Corp |
Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |